NCT01844791 - An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

OCZ103-OS

OCZ103-OS is given in combination with chemotherapy each cycle

DRUG

Platinum

Platinum is given as standard chemotherapy each cycle

DRUG

Gemcitabine

Gemcitabine is given as standard chemotherapy each cycle

Trial Locations (1)

Ewa Kalinka-Warzocha, Lodz